Michael Goldberg - 02 Jul 2026 Form 4 Insider Report for CareDx, Inc. (CDNA)

Reporting relationship: Director
Issuer ticker: CDNA
Reported as of: 02 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jul 2026, 17:53:29 UTC
Prior SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Adam Novack, Attorney-in-Fact

Key filing fact

Michael Goldberg filed Form 4 for CareDx, Inc. (CDNA) on 07 Jul 2026.

Key facts

This page summarizes Michael Goldberg's Form 4 filing for CareDx, Inc. (CDNA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jul 2026, 17:53.

Change

Previous filing in this sequence was filed on 16 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001366412 Primary reporting owner

Goldberg Michael

Relationship: Director
Address: C/O CAREDX, INC., 8000 MARINA BOULEVARD, 4TH FLOOR, BRISBANE
Signature: /s/ Jeffrey Adam Novack, Attorney-in-Fact
Signature date: 07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDNA transaction

Common Stock

Award

Transaction value
Shares: +1,746
Change %: +1.7%
Price: $0.000000^*
Shares after: 106,438
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1

CDNA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 91,045
Date: 02 Jul 2026
Ownership: See Footnote
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Footnote F2

Represents shares held by the Cavallo Trust of which the Reporting Person and the Reporting Person's spouse are trustees.